Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Dimensionality and Measurement Invariance of the Italian Version of the EORTC QLQ-C30 in Postoperative Lung Cancer Patients.

Marzorati C, Monzani D, Mazzocco K, Pavan F, Monturano M, Pravettoni G.

Front Psychol. 2019 Oct 8;10:2147. doi: 10.3389/fpsyg.2019.02147. eCollection 2019.

2.

Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study.

Morini M, Cangelosi D, Segalerba D, Marimpietri D, Raggi F, Castellano A, Fruci D, de Mora JF, Cañete A, Yáñez Y, Viprey V, Corrias MV, Carlini B, Pezzolo A, Schleiermacher G, Mazzocco K, Ladenstein R, Sementa AR, Conte M, Garaventa A, Burchill S, Luksch R, Bosco MC, Eva A, Varesio L.

Cancers (Basel). 2019 Sep 30;11(10). pii: E1476. doi: 10.3390/cancers11101476.

3.

How to Train Your Health: Sports as a Resource to Improve Cognitive Abilities in Cancer Patients.

Sebri V, Savioni L, Triberti S, Mazzocco K, Pravettoni G.

Front Psychol. 2019 Sep 13;10:2096. doi: 10.3389/fpsyg.2019.02096. eCollection 2019.

4.

Reply to Comments on: "Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines."

Munzone E, Pagan E, Bagnardi V, Mazzocco K.

Br J Cancer. 2019 Oct;121(9):806. doi: 10.1038/s41416-019-0577-4. Epub 2019 Sep 17. No abstract available.

PMID:
31527688
5.

Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159).

Marvaso G, Ciardo D, Corrao G, Gandini S, Fodor C, Zerini D, Rojas DP, Augugliaro M, Bonizzi G, Pece S, Cattani F, Mazzocco K, Mistretta FA, Musi G, Alessi S, Petralia G, Pravettoni G, De Cobelli O, Di Fiore PP, Viale G, Orecchia R, Jereczek-Fossa BA.

BMC Cancer. 2019 Sep 10;19(1):903. doi: 10.1186/s12885-019-6117-z.

6.

Validation of the Italian version of the abbreviated expanded prostate Cancer index composite (EPIC-26) in men with prostate Cancer.

Marzorati C, Monzani D, Mazzocco K, Masiero M, Pavan F, Monturano M, Pravettoni G.

Health Qual Life Outcomes. 2019 Aug 29;17(1):147. doi: 10.1186/s12955-019-1214-x.

7.

The Attentional Bias in Current and Former Smokers.

Masiero M, Lucchiari C, Maisonneuve P, Pravettoni G, Veronesi G, Mazzocco K.

Front Behav Neurosci. 2019 Jul 10;13:154. doi: 10.3389/fnbeh.2019.00154. eCollection 2019.

8.

Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines.

Munzone E, Bagnardi V, Campennì G, Mazzocco K, Pagan E, Tramacere A, Masiero M, Iorfida M, Mazza M, Montagna E, Cancello G, Bianco N, Palazzo A, Cardillo A, Dellapasqua S, Sangalli C, Pettini G, Pravettoni G, Colleoni M, Veronesi P.

Br J Cancer. 2019 Aug;121(4):325-331. doi: 10.1038/s41416-019-0520-8. Epub 2019 Jul 15.

PMID:
31303642
9.

Not Just a Pill: Toward a Tailored Antismoking Intervention for Respiratory Diseases.

Masiero M, Renzi C, Mazzocco K, Pravettoni G.

J Addict Nurs. 2019 Apr/Jun;30(2):E1-E4. doi: 10.1097/JAN.0000000000000276.

PMID:
31162220
10.

A Review of Infants With Localized Neuroblastoma That Evolve to Stage 4s Disease.

Caroleo AM, De Bernardi B, Avanzini S, Gigliotti AR, Muraca M, Pota E, Provenzi M, Mazzocco K, Sementa AR, Granata C, Sorrentino S.

J Pediatr Hematol Oncol. 2019 May 22. doi: 10.1097/MPH.0000000000001517. [Epub ahead of print]

PMID:
31135717
11.

The role of emotions in cancer patients' decision-making.

Mazzocco K, Masiero M, Carriero MC, Pravettoni G.

Ecancermedicalscience. 2019 Mar 28;13:914. doi: 10.3332/ecancer.2019.914. eCollection 2019. Review.

12.

Predicting trajectories of recovery in prostate cancer patients undergone Robot-Assisted Radical Prostatectomy (RARP).

Marzorati C, Monzani D, Mazzocco K, Pavan F, Cozzi G, De Cobelli O, Monturano M, Pravettoni G.

PLoS One. 2019 Apr 4;14(4):e0214682. doi: 10.1371/journal.pone.0214682. eCollection 2019.

13.

User-Centered Virtual Reality for Promoting Relaxation: An Innovative Approach.

Pizzoli SFM, Mazzocco K, Triberti S, Monzani D, Alcañiz Raya ML, Pravettoni G.

Front Psychol. 2019 Mar 12;10:479. doi: 10.3389/fpsyg.2019.00479. eCollection 2019.

14.

Training Cognitive Functions Using Mobile Apps in Breast Cancer Patients: Systematic Review.

Vergani L, Marton G, Pizzoli SFM, Monzani D, Mazzocco K, Pravettoni G.

JMIR Mhealth Uhealth. 2019 Mar 19;7(3):e10855. doi: 10.2196/10855. Review.

15.

Research-Tested Mobile Apps for Breast Cancer Care: Systematic Review.

Jongerius C, Russo S, Mazzocco K, Pravettoni G.

JMIR Mhealth Uhealth. 2019 Feb 11;7(2):e10930. doi: 10.2196/10930.

16.

Stage 4 s neuroblastoma: features, management and outcome of 268 cases from the Italian Neuroblastoma Registry.

De Bernardi B, Di Cataldo A, Garaventa A, Massirio P, Viscardi E, Podda MG, Castellano A, D'Angelo P, Tirtei E, Melchionda F, Vetrella S, De Leonardis F, D'Ippolito C, Tondo A, Nonnis A, Erminio G, Gigliotti AR, Mazzocco K, Haupt R.

Ital J Pediatr. 2019 Jan 11;45(1):8. doi: 10.1186/s13052-018-0599-1.

17.

Empowerment from patient's and caregiver's perspective in cancer care.

Marzorati C, Bailo L, Mazzocco K, Pravettoni G.

Health Psychol Open. 2018 Dec 5;5(2):2055102918815318. doi: 10.1177/2055102918815318. eCollection 2018 Jul-Dec.

18.

A P5 Approach to m-Health: Design Suggestions for Advanced Mobile Health Technology.

Gorini A, Mazzocco K, Triberti S, Sebri V, Savioni L, Pravettoni G.

Front Psychol. 2018 Oct 31;9:2066. doi: 10.3389/fpsyg.2018.02066. eCollection 2018.

19.

E-Cigarettes May Support Smokers With High Smoking-Related Risk Awareness to Stop Smoking in the Short Run: Preliminary Results by Randomized Controlled Trial.

Masiero M, Lucchiari C, Mazzocco K, Veronesi G, Maisonneuve P, Jemos C, Salè EO, Spina S, Bertolotti R, Pravettoni G.

Nicotine Tob Res. 2018 Sep 19. doi: 10.1093/ntr/nty175. [Epub ahead of print] No abstract available.

PMID:
30239904
20.

Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients' survival and indicate proteins targetable at onset of disease.

Esposito MR, Binatti A, Pantile M, Coppe A, Mazzocco K, Longo L, Capasso M, Lasorsa VA, Luksch R, Bortoluzzi S, Tonini GP.

Int J Cancer. 2018 Nov 15;143(10):2525-2536. doi: 10.1002/ijc.31748. Epub 2018 Sep 17.

PMID:
29992558
21.

Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect.

Corso G, Figueiredo J, La Vecchia C, Veronesi P, Pravettoni G, Macis D, Karam R, Lo Gullo R, Provenzano E, Toesca A, Mazzocco K, Carneiro F, Seruca R, Melo S, Schmitt F, Roviello F, De Scalzi AM, Intra M, Feroce I, De Camilli E, Villardita MG, Trentin C, De Lorenzi F, Bonanni B, Galimberti V.

J Med Genet. 2018 Jul;55(7):431-441. doi: 10.1136/jmedgenet-2018-105337. Epub 2018 Jun 21. Review.

PMID:
29929997
22.

Psycho-cognitive predictors of burnout in healthcare professionals working in emergency departments.

Masiero M, Cutica I, Russo S, Mazzocco K, Pravettoni G.

J Clin Nurs. 2018 Jul;27(13-14):2691-2698. doi: 10.1111/jocn.14376. Epub 2018 Jun 1.

PMID:
29856096
23.

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study.

Berbegall AP, Bogen D, Pötschger U, Beiske K, Bown N, Combaret V, Defferrari R, Jeison M, Mazzocco K, Varesio L, Vicha A, Ash S, Castel V, Coze C, Ladenstein R, Owens C, Papadakis V, Ruud E, Amann G, Sementa AR, Navarro S, Ambros PF, Noguera R, Ambros IM.

Br J Cancer. 2018 May;118(11):1502-1512. doi: 10.1038/s41416-018-0098-6. Epub 2018 May 14.

24.

E-cigarettes May Support Smokers With High Smoking-Related Risk Awareness to Stop Smoking in the Short Run: Preliminary Results by Randomized Controlled Trial.

Masiero M, Lucchiari C, Mazzocco K, Veronesi G, Maisonneuve P, Jemos C, Salè EO, Spina S, Bertolotti R, Pravettoni G.

Nicotine Tob Res. 2019 Jan 1;21(1):119-126. doi: 10.1093/ntr/nty047.

PMID:
29660034
25.

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.

Depuydt P, Boeva V, Hocking TD, Cannoodt R, Ambros IM, Ambros PF, Asgharzadeh S, Attiyeh EF, Combaret V, Defferrari R, Fischer M, Hero B, Hogarty MD, Irwin MS, Koster J, Kreissman S, Ladenstein R, Lapouble E, Laureys G, London WB, Mazzocco K, Nakagawara A, Noguera R, Ohira M, Park JR, Pötschger U, Theissen J, Tonini GP, Valteau-Couanet D, Varesio L, Versteeg R, Speleman F, Maris JM, Schleiermacher G, De Preter K.

J Natl Cancer Inst. 2018 Oct 1;110(10):1084-1093. doi: 10.1093/jnci/djy022.

26.

Decisions and the involvement of cancer patient survivors: a moral imperative.

Pravettoni G, Cutica I, Righetti S, Mazzocco K.

J Healthc Leadersh. 2016 Dec 7;8:121-125. doi: 10.2147/JHL.S115434. eCollection 2016.

27.

A Qualitative Investigation on Patient Empowerment in Prostate Cancer.

Renzi C, Fioretti C, Oliveri S, Mazzocco K, Zerini D, Alessandro O, Rojas DP, Jereczek-Fossa BA, Pravettoni G.

Front Psychol. 2017 Jul 26;8:1215. doi: 10.3389/fpsyg.2017.01215. eCollection 2017.

28.

Professor Umberto Veronesi: a physician, a researcher, a brilliant man.

Mazzocco K, Marzorati C, Pravettoni G.

Ecancermedicalscience. 2017 Jun 8;11:742. doi: 10.3332/ecancer.2017.742. eCollection 2017.

29.

Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.

Pezzolo A, Sementa AR, Lerone M, Morini M, Ognibene M, Defferrari R, Mazzocco K, Conte M, Gigliotti AR, Garaventa A, Pistoia V, Varesio L.

Cancer Biol Ther. 2017 May 4;18(5):285-289. doi: 10.1080/15384047.2017.1312231. Epub 2017 Apr 12.

30.

How many research nurses for how many clinical trials in an oncology setting? Definition of the Nursing Time Required by Clinical Trial-Assessment Tool (NTRCT-AT).

Milani A, Mazzocco K, Stucchi S, Magon G, Pravettoni G, Passoni C, Ciccarelli C, Tonali A, Profeta T, Saiani L.

Int J Nurs Pract. 2017 Feb;23(1). doi: 10.1111/ijn.12497. Epub 2016 Dec 7.

PMID:
27925377
31.

A web-based interactive tool to improve breast cancer patient centredness.

Gorini A, Mazzocco K, Kondylakis H, McVie G, Pravettoni G.

Ecancermedicalscience. 2016 Jul 26;10:659. doi: 10.3332/ecancer.2016.659. eCollection 2016.

32.

Promoting weight loss through diet and exercise in overweight or obese breast cancer survivors (InForma): study protocol for a randomized controlled trial.

Gnagnarella P, Dragà D, Baggi F, Simoncini MC, Sabbatini A, Mazzocco K, Bassi FD, Pravettoni G, Maisonneuve P.

Trials. 2016 Jul 28;17:363. doi: 10.1186/s13063-016-1487-x.

33.

Research studies on patients' illness experience using the Narrative Medicine approach: a systematic review.

Fioretti C, Mazzocco K, Riva S, Oliveri S, Masiero M, Pravettoni G.

BMJ Open. 2016 Jul 14;6(7):e011220. doi: 10.1136/bmjopen-2016-011220. Review.

34.

Psycho-emotional tools for better treatment adherence and therapeutic outcomes for cancer patients.

Kazantzaki E, Kondylakis H, Koumakis L, Marias K, Tsiknakis M, Fioretti C, Gorini A, Mazzocco K, Renzi C, Pravettoni G.

Stud Health Technol Inform. 2016;224:129-34.

35.

Piloting the European Unified Patient Identity Management (EUPID) Concept to Facilitate Secondary Use of Neuroblastoma Data from Clinical Trials and Biobanking.

Ebner H, Hayn D, Falgenhauer M, Nitzlnader M, Schleiermacher G, Haupt R, Erminio G, Defferrari R, Mazzocco K, Kohler J, Tonini GP, Ladenstein R, Schreier G.

Stud Health Technol Inform. 2016;223:31-8.

PMID:
27139382
36.

Incidence and Determinants of Port Occlusions in Cancer Outpatients: A Prospective Cohort Study.

Milani A, Mazzocco K, Gandini S, Pravettoni G, Libutti L, Zencovich C, Sbriglia A, Pari C, Magon G, Saiani L.

Cancer Nurs. 2017 Mar/Apr;40(2):102-107. doi: 10.1097/NCC.0000000000000357.

PMID:
26925994
37.

Understanding cognitive processes behind acceptance or refusal of phase I trials.

Pravettoni G, Mazzocco K, Gorini A, Curigliano G.

Crit Rev Oncol Hematol. 2016 Apr;100:69-73. doi: 10.1016/j.critrevonc.2016.01.023. Epub 2016 Jan 23. Review.

PMID:
26852078
38.

Rationale and protocol of CML study: cognitive and emotional impact of discontinuation of therapy in patients with chronic myeloid leukemia.

Riva S, Mazzocco K, Pravettoni G.

Tumori. 2016 Mar-Apr;102(2):217-21. doi: 10.5301/tj.5000451. Epub 2015 Dec 11.

PMID:
26689667
39.

Eliminating "ductal carcinoma in situ" and "lobular carcinoma in situ" (DCIS and LCIS) terminology in clinical breast practice: The cognitive psychology point of view.

Pravettoni G, Yoder WR, Riva S, Mazzocco K, Arnaboldi P, Galimberti V.

Breast. 2016 Feb;25:82-5. doi: 10.1016/j.breast.2015.10.011. Epub 2015 Nov 21.

PMID:
26614547
40.

Decision-Making Process Related to Participation in Phase I Clinical Trials: A Nonsystematic Review of the Existing Evidence.

Gorini A, Mazzocco K, Pravettoni G.

Public Health Genomics. 2015;18(6):359-65. doi: 10.1159/000441559. Epub 2015 Nov 4. Review.

PMID:
26529420
41.

The Paradox of Pelvic Exenteration: The Interaction of Clinical and Psychological Variables.

Arnaboldi P, Santoro L, Mazzocco K, Oliveri S, Maggioni A, Pravettoni G.

Int J Gynecol Cancer. 2015 Oct;25(8):1534-40. doi: 10.1097/IGC.0000000000000523.

PMID:
26244759
42.

Development and psychometric testing of a breast cancer patient-profiling questionnaire.

Gorini A, Mazzocco K, Gandini S, Munzone E, McVie G, Pravettoni G.

Breast Cancer (Dove Med Press). 2015 Jun 1;7:133-46. doi: 10.2147/BCTT.S80014. eCollection 2015.

43.

Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group.

Mazzocco K, Defferrari R, Sementa AR, Garaventa A, Longo L, De Mariano M, Esposito MR, Negri F, Ircolò D, Viscardi E, Luksch R, D'Angelo P, Prete A, Castellano A, Massirio P, Erminio G, Gigliotti AR, Tonini GP, Conte M.

Pediatr Blood Cancer. 2015 Oct;62(10):1725-32. doi: 10.1002/pbc.25552. Epub 2015 Apr 29.

PMID:
25925003
44.

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.

Defferrari R, Mazzocco K, Ambros IM, Ambros PF, Bedwell C, Beiske K, Bénard J, Berbegall AP, Bown N, Combaret V, Couturier J, Erminio G, Gambini C, Garaventa A, Gross N, Haupt R, Kohler J, Jeison M, Lunec J, Marques B, Martinsson T, Noguera R, Parodi S, Schleiermacher G, Tweddle DA, Valent A, Van Roy N, Vicha A, Villamon E, Tonini GP.

Br J Cancer. 2015 Jan 20;112(2):290-5. doi: 10.1038/bjc.2014.557. Epub 2014 Nov 4.

45.

Neuroblastoma in the adult: the Italian experience with 21 patients.

Sorrentino S, Gigliotti AR, Sementa AR, Morsellino V, Conte M, Erminio G, Buffa P, Granata C, Mazzocco K, Garaventa A, De Bernardi B.

J Pediatr Hematol Oncol. 2014 Nov;36(8):e499-505. doi: 10.1097/MPH.0000000000000144.

PMID:
24633299
46.

Development of interactive empowerment services in support of personalised medicine.

Kondylakis H, Kazantzaki E, Koumakis L, Genitsaridi I, Marias K, Gorini A, Mazzocco K, Pravettoni G, Burke D, McVie G, Tsiknakis M.

Ecancermedicalscience. 2014 Feb 11;8:400. doi: 10.3332/ecancer.2014.400. eCollection 2014. Review.

47.

Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy.

Passariello A, De Brasi D, Defferrari R, Genesio R, Tufano M, Mazzocco K, Capasso M, Migliorati R, Martinsson T, Siani P, Nitsch L, Tonini GP.

Eur J Med Genet. 2013 Nov;56(11):626-34. doi: 10.1016/j.ejmg.2013.08.005. Epub 2013 Sep 13.

PMID:
24035971
48.

Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins.

Morandi F, Scaruffi P, Gallo F, Stigliani S, Moretti S, Bonassi S, Gambini C, Mazzocco K, Fardin P, Haupt R, Arcamone G; Italian Cooperative Group for Neuroblastoma, Pistoia V, Tonini GP, Corrias MV.

PLoS One. 2012;7(1):e29922. doi: 10.1371/journal.pone.0029922. Epub 2012 Jan 9.

49.

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

Schleiermacher G, Michon J, Ribeiro A, Pierron G, Mosseri V, Rubie H, Munzer C, Bénard J, Auger N, Combaret V, Janoueix-Lerosey I, Pearson A, Tweddle DA, Bown N, Gerrard M, Wheeler K, Noguera R, Villamon E, Cañete A, Castel V, Marques B, de Lacerda A, Tonini GP, Mazzocco K, Defferrari R, de Bernardi B, di Cataldo A, van Roy N, Brichard B, Ladenstein R, Ambros I, Ambros P, Beiske K, Delattre O, Couturier J.

Br J Cancer. 2011 Dec 6;105(12):1940-8. doi: 10.1038/bjc.2011.472. Epub 2011 Nov 10.

50.

Pecunia olet: the role of incidental disgust in the ultimatum game.

Bonini N, Hadjichristidis C, Mazzocco K, Demattè ML, Zampini M, Sbarbati A, Magon S.

Emotion. 2011 Aug;11(4):965-9. doi: 10.1037/a0022820.

PMID:
21534658

Supplemental Content

Loading ...
Support Center